Klein NP - Search Results

1

Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers.

Hansen J, Timbol J, Lewis N, Pool V, Decker MD, Greenberg DP, Klein NP. Hansen J, et al. Among authors: klein np. Vaccine. 2016 Jul 29;34(35):4172-4179. doi: 10.1016/j.vaccine.2016.06.062. Epub 2016 Jun 30. Vaccine. 2016. PMID: 27373595 Free article. Clinical Trial.

2

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP. Black S, et al. Among authors: klein np. Pediatr Infect Dis J. 2007 Sep;26(9):771-7. doi: 10.1097/INF.0b013e318124a494. Pediatr Infect Dis J. 2007. PMID: 17721369

3

Differential maternal responses to a newly developed vaccine information pamphlet.

Klein NP, Kissner J, Aguirre A, Sparks R, Campbell S, Edwards KM, Dekker CL, Shui I, Gust DA. Klein NP, et al. Vaccine. 2009 Dec 11;28(2):323-8. doi: 10.1016/j.vaccine.2009.10.046. Epub 2009 Oct 30. Vaccine. 2009. PMID: 19879994

4

Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age.

Black S, Klein NP, Shah J, Bedell L, Karsten A, Dull PM. Black S, et al. Among authors: klein np. Vaccine. 2010 Jan 8;28(3):657-63. doi: 10.1016/j.vaccine.2009.10.104. Epub 2009 Nov 4. Vaccine. 2010. PMID: 19895922 Clinical Trial.

5

Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies.

Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, Black S, Galindo C, Schmidt J, Baxter R. Klein NP, et al. Vaccine. 2010 Jan 22;28(4):1062-8. doi: 10.1016/j.vaccine.2009.10.115. Epub 2009 Nov 5. Vaccine. 2010. PMID: 19896453

6

Preterm infants' T cell responses to inactivated poliovirus vaccine.

Klein NP, Gans HA, Sung P, Yasukawa LL, Johnson J, Sarafanov A, Chumakov K, Hansen J, Black S, Dekker CL. Klein NP, et al. J Infect Dis. 2010 Jan 15;201(2):214-22. doi: 10.1086/649590. J Infect Dis. 2010. PMID: 20017631

7

Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization.

Klein NP, Hansen J, Lewis E, Lyon L, Nguyen B, Black S, Weston WM, Wu S, Li P, Howe B, Friedland LR. Klein NP, et al. Pediatr Infect Dis J. 2010 Jul;29(7):613-7. doi: 10.1097/INF.0b013e3181d581f9. Pediatr Infect Dis J. 2010. PMID: 20190673

8

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.

Halperin SA, Gupta A, Jeanfreau R, Klein NP, Reisinger K, Walter E, Bedell L, Gill C, Dull PM. Halperin SA, et al. Among authors: klein np. Vaccine. 2010 Nov 23;28(50):7865-72. doi: 10.1016/j.vaccine.2010.09.092. Epub 2010 Oct 29. Vaccine. 2010. PMID: 20943209 Free article. Clinical Trial.

9

Vaccine safety in special populations.

Klein NP. Klein NP. Hum Vaccin. 2011 Feb;7(2):269-71. doi: 10.4161/hv.7.2.13860. Epub 2011 Feb 1. Hum Vaccin. 2011. PMID: 21307654 No abstract available.

10

Evaluation of immunization rates and safety among children with inborn errors of metabolism.

Klein NP, Aukes L, Lee J, Fireman B, Shapira SK, Slade B, Baxter R, Summar M. Klein NP, et al. Pediatrics. 2011 May;127(5):e1139-46. doi: 10.1542/peds.2010-3706. Epub 2011 Apr 11. Pediatrics. 2011. PMID: 21482602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters